Skip to main content
Please enter a legal issue and/or a location
Begin typing to search, use arrow keys to navigate, use enter to select

Find a Lawyer

More Options

Panel: Avandia Should Remain on Market Despite Risks

By Admin on July 31, 2007 | Last updated on March 21, 2019

A U.S. Food and Drug Administration (FDA) advisory committee is recommending that diabetes medication Avandia remain on the market despite evidence that use of the drug increases the risk of heart attacks. According to the New York Times, "[t]he votes - 20 to 3 on the heart attack risk and 22 to 1 on the marketing - were cast after an extraordinary meeting in which officials from the Food and Drug Administration, which brought the committee together, openly disagreed with one another on the course to take." The panel advised the FDA that Avandia labeling should carry warnings of the increased risk of heart attack associated with the drug's use.

You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help

Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.

Or contact an attorney near you:
Copied to clipboard